Zhejiang Zhenyuan Share Co.,Ltd. (SHE:000705)
6.93
-0.11 (-1.56%)
Aug 24, 2026, 3:04 PM CST
Zhejiang Zhenyuan Share Revenue
Zhejiang Zhenyuan Share had revenue of 431.30M CNY in the quarter ending June 30, 2026, a decrease of -18.87%. This brings the company's revenue in the last twelve months to 1.86B, down -39.18% year-over-year. In the year 2025, Zhejiang Zhenyuan Share had annual revenue of 2.28B, down -39.17%.
Revenue (ttm)
1.86B
Revenue Growth
-39.18%
P/S Ratio
1.24
Revenue / Employee
987.90K
Employees
1,887
Market Cap
2.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.28B | -1.47B | -39.17% |
| Dec 31, 2024 | 3.74B | -365.68M | -8.91% |
| Dec 31, 2023 | 4.11B | -39.11M | -0.94% |
| Dec 31, 2022 | 4.15B | 533.43M | 14.77% |
| Dec 31, 2021 | 3.61B | 172.20M | 5.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 33.84B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.90B |
| GuangYuYuan Chinese Herbal Medicine | 1.44B |
| Hangzhou Minsheng Healthcare | 827.65M |
| Chongqing Lummy Pharmaceutical | 748.94M |
| Hangzhou Bio-Sincerity Pharma-Tech | 709.72M |
| Hubei Guangji Pharmaceutical | 638.58M |
| Zhejiang Haisen Pharmaceutical | 541.06M |